These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9282168

  • 1. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
    Qazilbash MH, Xiao X, Seth P, Cowan KH, Walsh CE.
    Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168
    [Abstract] [Full Text] [Related]

  • 2. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
    Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM, Amin KM.
    Cancer Gene Ther; 1999 Jul; 6(4):291-301. PubMed ID: 10419047
    [Abstract] [Full Text] [Related]

  • 3. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA.
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [Abstract] [Full Text] [Related]

  • 4. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
    Rohr UP, Wulf MA, Stahn S, Heyd F, Steidl U, Fenk R, Opalka B, Pitschke G, Prisack HB, Bojar H, Haas R, Kronenwett R.
    Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
    [Abstract] [Full Text] [Related]

  • 5. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE.
    Cancer Res; 2000 Jul 01; 60(13):3655-61. PubMed ID: 10910082
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
    Riccioni T, Cirielli C, Wang X, Passaniti A, Capogrossi MC.
    Gene Ther; 1998 Jun 01; 5(6):747-54. PubMed ID: 9747454
    [Abstract] [Full Text] [Related]

  • 7. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
    Ruifa H, Liwei L, Binxin L, Ximing L.
    Urol Int; 2006 Jun 01; 77(4):355-61. PubMed ID: 17135787
    [Abstract] [Full Text] [Related]

  • 8. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
    Cajot JF, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ.
    Cancer Res; 1992 Dec 15; 52(24):6956-60. PubMed ID: 1458487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J, Leng X, Peng J.
    Zhonghua Yi Xue Za Zhi; 2000 Jun 15; 80(6):461-3. PubMed ID: 11798803
    [Abstract] [Full Text] [Related]

  • 13. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
    Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N.
    Gynecol Oncol; 2002 Feb 15; 84(2):210-5. PubMed ID: 11812076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J, Choi S, Hwang KS, Cho WK, Jung CR, Kwon ST, Im DS.
    J Gene Med; 2006 Feb 15; 8(2):163-74. PubMed ID: 16144019
    [Abstract] [Full Text] [Related]

  • 17. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol.
    Mukhopadhyay T, Roth JA.
    Oncogene; 1997 Jan 23; 14(3):379-84. PubMed ID: 9018125
    [Abstract] [Full Text] [Related]

  • 19. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H, Lai B, Li J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 23; 21(5):268-72. PubMed ID: 11326947
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
    Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK.
    Clin Cancer Res; 2001 Jun 23; 7(6):1765-72. PubMed ID: 11410518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.